Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,996 | 701 | 75.6% |
| Travel and Lodging | $5,085 | 15 | 24.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67.00 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $5,309 | 122 | $0 (2020) |
| Vertiflex, Inc. | $2,433 | 28 | $0 (2019) |
| Nuvectra Corporation | $2,137 | 5 | $0 (2018) |
| Nevro Corp. | $2,039 | 18 | $0 (2022) |
| Daiichi Sankyo Inc. | $1,456 | 110 | $0 (2019) |
| Stimwave Technologies Incorporated | $609.55 | 10 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $608.44 | 53 | $0 (2024) |
| Abbott Laboratories | $545.65 | 23 | $0 (2024) |
| Zyla Life Sciences | $422.93 | 64 | $0 (2019) |
| Egalet US Inc | $396.88 | 43 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,150 | 58 | BIOTRONIK NRO, Inc. ($172.72) |
| 2023 | $1,118 | 52 | Abbott Laboratories ($196.41) |
| 2022 | $897.86 | 28 | Medtronic, Inc. ($189.31) |
| 2021 | $293.94 | 10 | BOSTON SCIENTIFIC CORPORATION ($150.06) |
| 2020 | $323.52 | 7 | Medtronic USA, Inc. ($286.05) |
| 2019 | $4,746 | 210 | Medtronic USA, Inc. ($2,295) |
| 2018 | $11,001 | 293 | Medtronic USA, Inc. ($2,375) |
| 2017 | $1,617 | 60 | Nevro Corp. ($409.57) |
All Payment Transactions
718 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.83 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.48 | General |
| Category: Opioid Analgesic | ||||||
| 10/15/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: Opioid Analgesic | ||||||
| 10/11/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Not Applicable | ||||||
| 10/11/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Neuromodulation | ||||||
| 10/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Clinical Trial Product_NMD | ||||||
| 09/24/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.77 | General |
| Category: NEUROLOGY | ||||||
| 09/09/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Neuromodulation | ||||||
| 09/09/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Neuromodulation | ||||||
| 09/09/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: Neuromodulation | ||||||
| 09/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Neuromodulation | ||||||
| 09/03/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/29/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/20/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Analgesic | ||||||
| 08/15/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: PAIN | ||||||
| 08/13/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $6.11 | General |
| Category: Opioid Analgesic | ||||||
| 08/09/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Not Applicable | ||||||
| 08/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: PAIN | ||||||
| 08/01/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: PAIN | ||||||
| 07/31/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.67 | General |
| Category: Opioid Analgesic | ||||||
| 07/22/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Neuromodulation | ||||||
| 07/16/2024 | Becton, Dickinson and Company | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $25.00 | General |
| 07/16/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $7.09 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 546 | 1,145 | $648,226 | $72,735 |
| 2022 | 16 | 762 | 1,226 | $819,341 | $96,027 |
| 2021 | 22 | 1,358 | 4,720 | $2.7M | $379,157 |
| 2020 | 22 | 1,537 | 5,116 | $2.9M | $386,080 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 274 | $96,048 | $26,122 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 341 | $91,250 | $23,300 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $15,981 | $3,514 | 22.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 15 | 21 | $66,400 | $3,250 | 4.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 20 | 29 | $77,600 | $2,762 | 3.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 14 | 20 | $45,000 | $1,953 | 4.3% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 12 | 17 | $44,100 | $1,905 | 4.3% |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 2023 | 29 | 29 | $7,300 | $1,849 | 25.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 26 | $8,350 | $1,522 | 18.2% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 12 | 17 | $32,900 | $1,077 | 3.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 13 | 19 | $33,820 | $1,050 | 3.1% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 14 | 22 | $40,401 | $1,023 | 2.5% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 11 | 14 | $7,380 | $1,016 | 13.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 61 | 70 | $14,240 | $857.05 | 6.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 34 | 75 | $37,550 | $745.50 | 2.0% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 12 | 17 | $28,460 | $711.21 | 2.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 92 | $1,380 | $74.17 | 5.4% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 21 | 33 | $66.00 | $3.81 | 5.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 331 | 699 | $352,981 | $59,679 | 16.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $33,299 | $5,630 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 80 | $25,801 | $5,433 | 21.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 36 | 40 | $93,176 | $4,721 | 5.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 49 | 61 | $26,840 | $3,791 | 14.1% |
| 01992 | Anesthesia for nerve block and injection procedure, prone position | Facility | 2022 | 30 | 34 | $46,949 | $3,320 | 7.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 11 | 13 | $51,366 | $2,274 | 4.4% |
About Dr. Ruben Alexander, MD
Dr. Ruben Alexander, MD is a Anesthesiology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2011. The National Provider Identifier (NPI) number assigned to this provider is 1790078848.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ruben Alexander, MD has received a total of $21,147 in payments from pharmaceutical and medical device companies, with $1,150 received in 2024. These payments were reported across 718 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($15,996).
As a Medicare-enrolled provider, Alexander has provided services to 4,203 Medicare beneficiaries, totaling 12,207 services with total Medicare billing of $933,999. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Surgery, Pain Medicine
- Location Las Vegas, NV
- Active Since 05/24/2011
- Last Updated 07/21/2022
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1790078848
Products in Payments
- Superion ISS (Device) $2,433
- MYSTIM (Device) $2,152
- Algovita (Device) $2,137
- Senza Spinal Cord Stimulation System (Device) $1,893
- INTELLIS (Device) $1,433
- Morphabond ER (Drug) $1,277
- ADAPTIVESTIM (Device) $1,110
- SPRIX (Drug) $718.38
- TARGETSTIM (Device) $491.53
- PROCLAIM (Device) $339.17
- Gralise (Drug) $293.90
- INTELLIS ADAPTIVESTIM (Device) $264.70
- Belbuca (Drug) $231.98
- BOTOX (Biological) $226.00
- ZTLido (Drug) $222.48
- RELISTOR (Drug) $191.44
- XTAMPZA (Drug) $186.22
- Nimbus (Device) $182.24
- SYMPROIC (Drug) $180.65
- Prospera (Device) $172.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Las Vegas
Mr. Edward Lizano, M.d, M.D
Anesthesiology — Payments: $1.4M
Dr. Steven Evans, M.d, M.D
Anesthesiology — Payments: $47,166
Nader Helmi, Do, DO
Anesthesiology — Payments: $25,125
Dr. Khuram Khan, Do, DO
Anesthesiology — Payments: $22,442
William Baumgartl, Md, MD
Anesthesiology — Payments: $19,409
Stephen Gephardt, Md, MD
Anesthesiology — Payments: $17,104